Currently, magnetic resonance imaging (MRI) is used 1-3 months after treatment to evaluate anatomical tumor response, based upon changes in tumor size and contrast-agent enhancement.
目前,人们基于肿瘤大小和对比剂增强变化之原理,在治疗后1 - 3个月时,用磁共振成像(MRI)来评估解剖学上的肿瘤反应。
And observing the changes of their sings and symptoms and quality of life before treatment and after finishing the periods of treatment for 3 months.
并于治疗前及疗程结束后第3个月,用量表评定患者治疗后近期内临床症候和生存质量的变化。
Serum CA125 and TSGF increased in 16 out of 51 follow-up cases. They were clinically confirmed to metastasize or recur within 3 ~ 12 months with serological changes.
随访51例术后患者中,有16例患者血清CA125和(或)TSGF升高,在血清学变化的3 ~ 12个月内被临床证实转移或复发。
应用推荐